We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Automatic Defibrillators Boost Cardiac Arrest Survival

By HospiMedica staff writers
Posted on 29 Jan 2002
A large US teaching hospital has reported a vast improvement in the survival of cardiac arrest patients since the installation of automatic external bedside defibrillators.

The defibrillators were installed in the cardiac care and intensive care units, step-down telemetry wards, and emergency room. More...
In the first four months of deployment, many therapy interventions were made by the devices, according to the hospital. In all cases, patients were successfully returned to normal cardiac rhythm in a matter of seconds. Because of the immediate intervention, there was no need for the crash-cart team and none of the patients required intubation. As a result, the hospital has increased the number of defibrillators available from 68 to 104.

The American Heart Association (AHA) revised its guidelines last year for cardiopulmonary resuscitation (CPR) and emergency cardiac care, placing major emphasis on the need for immediate defibrillation. The AHA stated that reducing the time to first shock by as little as one minute does more to improve patient survival than all current resuscitation interventions combined. Currently only about 20% of US patients experiencing cardiac arrest survive to discharge.

The hospital, Maimonides Medical Center (Brooklyn, New York, USA), used the Powerheart defibrillator, developed by Cardiac Science, Inc. (Irvine, CA, USA). When the Powerheart senses an abnormal heart rhythm, it automatically provides a brief electric shock through the patient's chest to the heart, restoring normal rhythm.

"The impact made at Maimonides by Powerheart technology has been dramatic and has facilitated a fundamental change in our approach to the treatment of cardiac arrest,” said Gerald Hollander, M.D., director of clinical cardiology at Maimonides. "The time from arrhythmia onset to successful defibrillation has been greatly reduced.”




Related Links:
Cardiac Science

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.